Skip to main content
Caplight Logo









Luminare

Luminare

Private
Houston, TexasHealthcare & Life Scienceshttps://luminarehealth.com

Last Round

Accelerator

Mar 29, 2024

Total Funding Raised

$597,500

Company Overview

Luminare is a healthcare technology company that provides software-driven workflow optimization and clinical decision support tools, including its flagship sepsis management platform, Sagitta.

Sector

Healthcare & Life Sciences

Verticals

InsurTech, Revenue Cycle, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

TPAthird-party administratorself-funded health planhealth plan administrationclaims processingself-insured employercost containmentbenefits administrationmedical cost managementadministrative services onlyASOclaims auditingutilization managementhealthcare analyticsPPO network

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Luminare Comparables

Compare Luminare with similar companies based on industry and business-model similarity.

Luminare comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lucent Health
86%
Allied Benefit Systems
82%
GuideWell
82%

Luminare Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMar 29, 2024
AcceleratorAug 23, 2022
AcceleratorJun 7, 2018
SeedJun 14, 2017

Luminare Investors

Notable investors and investment history

Luminare investors
InvestorRounds
Carnrite VenturesSeed
RedHouse AssociatesSeed
Cedars-Sinai AcceleratorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 29, 2024

    Completed an accelerator round of funding.

  • Jun 7, 2018

    Completed an Accelerator round of funding.

Luminare Filings

Explore SEC and related filing metadata, where available.

Luminare filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Luminare's valuation, stock price, and market status.

Is Luminare a public or private company?

Luminare is a private company.

What is the current stock price of Luminare?

Luminare is a private company with no public stock price. No recent secondary market data is available.

How much is Luminare worth (valuation)?

Valuation information for Luminare is not publicly available.

Can I buy Luminare stock?

Luminare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Luminare's last funding round?

Luminare's most recent funding round was Accelerator on March 29, 2024.

Who are the main investors in Luminare?

Key investors in Luminare include Cedars-Sinai Accelerator.

Will Luminare IPO soon?

No public IPO plans have been announced for Luminare.

How can I track Luminare secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Luminare's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHouston, Texas
Year Founded2014
Last FundingMar 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?